Amended Statement of Changes in Beneficial Ownership (4/a)
16 Agosto 2021 - 1:25PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
KESTER W CARL |
2. Issuer Name and Ticker or Trading Symbol
BlackRock Science & Technology Trust
[
BST
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below)
|
(Last)
(First)
(Middle)
55 EAST 52ND STREET |
3. Date of Earliest Transaction
(MM/DD/YYYY)
6/28/2021 |
(Street)
NEW YORK, NY 10055
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
7/7/2021 |
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock | 6/28/2021 | | X | | 33 | A | (1) | 133 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Transferable Subscription Rights (Right to Buy) (1)(2) | (1)(2) | 6/28/2021 | | X | | | 100 | 6/18/2021 | 7/14/2021 | Common Stock | 33 | (1) | 0 | D | |
Explanation of Responses: |
(1) | On June 9, 2021, BlackRock Science and Technology Trust (the "Fund") announced the terms of a pro rata offering of transferable rights (the "Rights") to holders of the Fund's common shares, as of the record date of June 18, 2021 ("Record Date Shareholder"), entitling the holders of such rights to subscribe for up to an aggregate of 8,417,857 of the Fund's common shares (the "Rights Offering"). Record Date Shareholders received one Right for each outstanding whole common share held on the record date. The Rights entitle their holders to purchase one new common share for every three Rights held; however, any Record Date Shareholder who owns fewer than three common shares as of the Record Date will be entitled to subscribe for one common share. The estimated subscription price per common share is $56.74. |
(2) | This Form 4 amendment is being filed to correct the original Form 4 filing on July 7, 2021 to reflect that the reporting person did not participate in the oversubscription privilege with respect to the Rights Offering. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
KESTER W CARL 55 EAST 52ND STREET NEW YORK, NY 10055 | X |
|
|
|
Signatures
|
/s/ Dean A. Caruvana as Attorney-in-Fact | | 8/16/2021 |
**Signature of Reporting Person | Date |
BlackRock Science and Te... (NYSE:BST)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
BlackRock Science and Te... (NYSE:BST)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024